NewSquare Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

NewSquare Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-250	Closed	-$22K	–	355
2018 Q1	$22K	Buy	+250	New	+$22.8K	﹤0.01%	202
2016 Q2	–	Sell	-226	Closed	-$12K	–	409
2016 Q1	$12K	Hold	226	–	–	﹤0.01%	275
2015 Q4	$16K	Hold	226	–	–	﹤0.01%	215
2015 Q3	$14K	Buy	226 +1	+0.4%	+$79	﹤0.01%	211
2015 Q2	$19K	Buy	+225	New	+$17.5K	0.01%	215

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

NewSquare Capital's XBI Position: Q2 2018 in Review

NewSquare Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2018, closing a stake of 250 shares — an estimated $22K sold.

NewSquare Capital first reported a position in XBI in Q2 2015 and held it in 5 quarters. The position peaked at $22K in Q1 2018. 430 funds tracked by Wall St. Rank hold XBI as of Q2 2018.

NewSquare Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2018 after selling out during the quarter.
NewSquare Capital sold 250 State Street SPDR S&P Biotech ETF shares in Q2 2018, an estimated $22K.
NewSquare Capital first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and held it in 5 quarters.
NewSquare Capital's State Street SPDR S&P Biotech ETF position peaked at $22K in Q1 2018.
430 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2018.

Based on NewSquare Capital's 13F filing for Q2 2018, filed 23 Jul 2018.